We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.74B
AUM Growth
+$18.9M
Cap. Flow
-$61.5M
Cap. Flow %
-3.53%
Top 10 Hldgs %
23.9%
Holding
276
New
11
Increased
44
Reduced
193
Closed
16

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$13M
2
DOCS icon
Doximity
DOCS
+$10.2M
3
LOB icon
Live Oak Bancshares
LOB
+$7.32M
4
RXO icon
RXO
RXO
+$7.31M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.78M

Top Sells

Rank Stock Value
1
AERI
Aerie Pharmaceuticals
AERI
+$24.3M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$12.4M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$12.3M
4
XPO icon
XPO
XPO
+$7.84M
5
RXT icon
Rackspace Technology
RXT
+$5.42M

Sector Composition

Rank Sector Weight
1 Technology 27.01%
2 Healthcare 26.13%
3 Industrials 15.45%
4 Consumer Discretionary 11.41%
5 Communication Services 6.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLGT icon
176
Radiant Logistics
RLGT
$391M
$2.23M 0.13%
437,310
-18,074
-4% -$101K
FMC icon
177
FMC
FMC
$1.31B
$2.19M 0.13%
17,567
-2,327
-12% -$285K
JOUT icon
178
Johnson Outdoors
JOUT
$515M
$2.19M 0.13%
33,095
-1,451
-4% -$81.5K
MX icon
179
Magnachip Semiconductor
MX
$141M
$2.18M 0.13%
232,211
-9,655
-4% -$93.3K
XYL icon
180
Xylem
XYL
$28.3B
$2.17M 0.12%
19,651
-4,104
-17% -$430K
CALY
181
Callaway Golf Company
CALY
$3.11B
$2.16M 0.12%
109,554
-8,036
-7% -$158K
FATE icon
182
Fate Therapeutics
FATE
$325M
$2.15M 0.12%
212,864
-6,282
-3% -$118K
BRKR icon
183
Bruker
BRKR
$8.5B
$2.14M 0.12%
31,292
-6,954
-18% -$442K
AZTA icon
184
Azenta
AZTA
$1.51B
$2.12M 0.12%
36,434
-2,700
-7% -$138K
IRMD icon
185
iRadimed
IRMD
$1.17B
$2.07M 0.12%
73,238
-2,968
-4% -$84.9K
BWXT icon
186
BWX Technologies
BWXT
$15.7B
$2.07M 0.12%
35,605
+2,983
+9% +$171K
CERS icon
187
Cerus
CERS
$480M
$2.02M 0.12%
554,792
-17,570
-3% -$66.2K
FNKO icon
188
Funko
FNKO
$349M
$2.01M 0.12%
184,625
-7,385
-4% -$104K
ZBH icon
189
Zimmer Biomet
ZBH
$18.3B
$1.96M 0.11%
15,397
-485
-3% -$56.3K
CXT icon
190
Crane NXT
CXT
$2.96B
$1.95M 0.11%
56,008
-711
-1% -$24.8K
IWM icon
191
iShares Russell 2000 ETF
IWM
$81.6B
$1.95M 0.11%
+11,198
New +$1.99M
LIND icon
192
Lindblad Expeditions
LIND
$2.2B
$1.92M 0.11%
+249,995
New +$2.11M
PRVB
193
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1.92M 0.11%
181,980
-39,621
-18% -$320K
TECH icon
194
Bio-Techne
TECH
$11.3B
$1.88M 0.11%
22,700
-4,332
-16% -$344K
DBI icon
195
Designer Brands
DBI
$332M
$1.87M 0.11%
190,884
-5,914
-3% -$79.8K
KEX icon
196
Kirby Corp
KEX
$6.96B
$1.83M 0.1%
28,418
– –
TTC icon
197
Toro Company
TTC
$9.4B
$1.82M 0.1%
16,053
-4,904
-23% -$520K
KNX icon
198
Knight Transportation
KNX
$11.3B
$1.81M 0.1%
34,534
-492
-1% -$25.4K
JNJ icon
199
Johnson & Johnson
JNJ
$626B
$1.8M 0.1%
10,207
-895
-8% -$155K
THS
200
DELISTED
Treehouse Foods
THS
$1.8M 0.1%
36,462
-1,003
-3% -$47.7K
6 7
8
9 10

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Rice Hall James & Associates held 276 positions worth $1.74B, up 1.1% from $1.72B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $61.5M in Q4 2022, closing 16 positions and reducing 193 holdings. Its most notable exit was Aerie Pharmaceuticals, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in OmniAb worth $8.94M.

  • Rice Hall James & Associates's largest Q4 2022 buy was OmniAb: 2,483,766 shares worth $8.94M.
  • Rice Hall James & Associates added most to Doximity in Q4 2022, an estimated $10.2M increase.
  • Rice Hall James & Associates's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $12.3M.
  • Rice Hall James & Associates fully exited Aerie Pharmaceuticals in Q4 2022, selling an estimated $24.3M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.74B portfolio in Q4 2022.
  • Rice Hall James & Associates opened 11 new positions and closed 16 in Q4 2022.
  • Rice Hall James & Associates's portfolio value rose 1.1% quarter-over-quarter to $1.74B.

Based on Rice Hall James & Associates's 13F filing for Q4 2022, filed 27 Jan 2023.